Hep C Discussion Forum

Members Login
Username 
 
Password 
    Remember Me  
Chatbox
Please log in to join the chat!
Hep C Discussion Forum -> Hep C News -> Abbvie announces 100% SVR12 response in Turquoise-111 Phase 3b study results
Post Info TOPIC: Abbvie announces 100% SVR12 response in Turquoise-111 Phase 3b study results
coolheat


Senior Member

Status: Offline
Posts: 209
Date:
RE: Abbvie announces 100% SVR12 response in Turquoise-111 Phase 3b study results
Permalink  
 

That is so wonderful!!!! Clouds are opening up, gold light is pouring through.....

__________________

65 YO F, GT 1a1b, ast 14 alt 21, fibrosis 3/4 DX 1968 non a or b, TX 12 wks Harvoni, SOT 6.1.15, 1st bld wk: detected unquantifiable EOT 8.28.15 detected unquantifiable, 3 mo.EOT mid Nov.~SVR 12: ) UNDETECTED
Cinnamon Girl


Guru

Status: Offline
Posts: 5629
Date:
Permalink  
 

NORTH CHICAGO, Ill., June 24,2015

AbbVie today announced TURQUOISE-III study results demonstrating 100 percent (n=60/60) sustained virologic response at 12 weeks post-treatment (SVR12) in genotype 1b chronic hepatitis C virus infected adult patients with compensated liver cirrhosis. 

Patients received 12 weeks of VIEKIRAX (ombitasvir/paritaprevir/ritonavir tablets) + EXVIERA (dasabuvir tablets) without ribavirin.  These new results from AbbVie's Phase 3b study will be presented at the 15th Annual International Symposium on Viral Hepatitis and Liver Diseases in Berlin, Germany.

Full details...

http://hcvadvocate.blogspot.ca/2015/06/abbvie-announces-new-phase-3b-results.html



__________________

Jill 

(71 yo, lives in UK)

Was Gen 3a, 

24wks Peg Ifn/Riba, Sep 2010 - Mch 2011

UND @ Wk.4, UND @ EOT, 

SVR Nov 2011 --> Still UND @ EOT + 4 yrs.

 

 
Page 1 of 1  sorted by
 
Quick Reply

Please log in to post quick replies.
Hep C Discussion Forum -> Hep C News -> Abbvie announces 100% SVR12 response in Turquoise-111 Phase 3b study results
Legal Disclaimer:

THIS FORUM, IT'S OWNERS, ADMINISTRATORS, MODERATORS AND MEMBERS DO NOT AT ANY TIME GIVE MEDICAL ADVICE AND IN ALL CASES REFER ANYONE HERE TO SEEK APPROPRIATE MEDICAL ADVICE FROM THEIR DOCTOR.